{"symbol":"BMY","fiscalQuarter":"Q1-2009","reportDate":"2009-04-28","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q1-2009","postBrief":{"headline":"Bristol Myers Squibb Beats on EPS, Stock Down 4.3%","keyNumbers":[{"metric":"EPS","actual":"$0.48","expected":"N/A","surprise":"+1.69%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted the importance of ongoing research and development.","They expressed confidence in their pipeline but acknowledged market challenges."],"summary":"Overall, management conveyed a cautious optimism regarding future growth. They emphasized the need to navigate current market conditions while focusing on innovation."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Bristol Myers Squibb's earnings report showed a small beat on EPS, but the stock fell by 4.3% in reaction. Investors may be concerned about the lack of revenue details and forward guidance, which could indicate uncertainty about future performance. The cautious tone from management suggests they are aware of challenges ahead, which may have contributed to the stock's decline.","metaDescription":"Bristol Myers Squibb (BMY) Q1 2009 earnings: EPS beat by 1.69%. Stock down 4.3%. Full breakdown."}}